Autonomic Dysreflexia Flashcards
Autonomic Dysreflexia can develop with injury at what level
at or above T6
Ischemic Cardiac symptoms in SCI pt
dyspnea, nausea, increased tone
Autonomic Dysreflexia characterized by
-unopposed sympathetic response to a noxious stimulus below the injury level resulting in an increase in blood pressure >20 mmHg above baseline
-associated with headache and vision changes.
SCI patient experiencing Autonomic Dysfunction with elevated BP
pt with SCI is experiencing AD, the noxious stimulus should be identified and addressed so blood pressure will go down as result.
-If stimulus cannot be identified, and blood pressure remains elevated, administer a vasodilatory agent (nitropaste, clonidine, or hydralazine) and continue to look for the stimulus.
compensatory parasympathetic response of autonomic dysreflexia
headache, nasal congestion, flushing
this is an emergency
Potential issues due to a cervical SCI and impaired diaphragm function
Impaired diaphragm function 2’ to cervical SCI associated with ventilation impairment, dysphagia, and aspiration risk.
-Providers should encourage chest physiotherapy, deep breathing exercises, monitor for signs of pulmonary infection, encourage vaccination against influenza and pneumococcus.
individuals with spinal injury above S2-S4, an upper motor neuron bladder can lead to
Neurogenic bladder from injury above S2-S4, typically have an upper motor neuron bladder which can result in high bladder pressures and contribute to vesicoureteral reflux.
-should be evaluated by urology, undergo urodynamic studies regularly, undergo an annual renal ultrasound.
-Pts will often require chronic intermittent catheterization or indwelling catheters for bladder maintenance.
Where are individuals with SCI at the highest risk for heterotopic ossification?
Hip joint
woman with SCI experiencing shoulder pain
most likely rotator cuff
Managment of spasticity
-consequence is contracture
-Spasticity often requires systemic meds (eg baclofen, localized chemodenervation with phenol or botulinum toxin), or intrathecal baclofen.
Untreated spasticity puts pts at risk for contractures, prevents adequate hygiene, causes pain.
-increase in spasticity can be the hallmark symptom of other pathology eg infections or pain.
management of individual with SCI experiencing neurogenic bladder
-may not exhibit typical signs of urinary tract infections. should be monitored for alternative symptoms
-Individuals with SCI often experience both neurogenic bladder and neurogenic bowel, which requires close management.
-at risk for urinary tract infections, hydronephrosis, nephrolithiasis, and pyelonephritis.
-may not exhibit typical signs so monitor for alternative symptoms such as fatigue, malaise, increased spasticity, fevers.
-these patients will also have chronic asymptomatic bacteriuria and careful examination and history should be done to rule out other causes of infection
orthostatic hypotension several years post injury and without prior history of orthostatic hypotension
Consider an MRI imaging to r/o development of syrinx
SCI and osteoporosis risk
-risk of osteoporosis below level of injury, therefore at risk for osteoporotic fractures
-monitor vitamin D levels and assess for additional risk factors
U.S. Access Board finalized voluntary standards for Accessible Medical Diagnostic Equipment in January 2017
-benefits for providers and patients include reducing disparities in access to preventive health care for people with mobility-related disabilities
-providing opportunities to reduce potential workplace injuries, liability, and employee attrition by curtailing the need for clinic staff to physically transfer patients to and from inaccessible examination equipment with cost-effective alternatives.
Immunization in pt w SCI
As normal, pt w/ SCI require immunizations and are at higher risk for respiratory compromise and a higher risk of pulmonary infection.
-highly recommended to receive the annual influenza vaccine, as with general population.
-Pts with injury above T8 are considered high risk so consider pneumococcal vaccine earlier than the general population.